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A
pproximately 36% of East 
Asians (Japanese, Chinese, and 
Koreans) show a characteristic 
physiological response to drinking 
alcohol that includes facial flushing 
(see Figure 1), nausea, and tachycardia 
[1] . This so-called alcohol flushing 
response (also known as “Asian flush” 
or “Asian glow”) is predominantly 
due to an inherited deficiency in the 
enzyme aldehyde dehydrogenase 2 
(ALDH2) [2]. Although clinicians 
and the East Asian publicgenerally
know about the alcohol flushing 
response (e.g., http://www.echeng.
com/asianblush/), few are aware 
of the accumulating evidence that 
ALDH2-deficient individuals are at 
much higher risk of esophageal cancer 
(specifically squamous cell carcinoma) 
from alcohol consumption than 
individuals with fully active ALDH2. 
This is particularly unfortunate as 
esophageal cancer is one of the 
deadliestcancers worldwide [3], with 
five-year survival rates of 15.6% in the 
United States, 12.3% in Europe, and 
31.6% in Japan [4].
Our goal in writing this article is 
to inform doctors firstly that their 
ALDH2-deficient patients have an 
increased risk for esophageal cancer 
if they drink moderate amounts of 
alcohol, and secondly that the alcohol 
flushing response is a biomarker 
for ALDH2 deficiency. Because of 
the intensity of the symptoms, most 
people who have the alcohol flushing 
response are aware of it. Therefore 
clinicians can determine ALDH2 
deficiency simply by asking about 
previous episodes of alcohol-induced 
flushing. As a result, ALDH2-deficient 
patients can then be counseled to 
reduce alcohol consumption, and 
high-risk patients can be assessed for 
endoscopic cancer screening. Based on 
the sizes of the Japanese, Chinese, and 
Korean populations and the expected 
frequency of ALDH2-deficient 
individuals in each [1], we estimate that 
there are at least 540 million ALDH2-
deficient individuals in the world, 
representing approximately 8% of the 
population. In a population of this size, 
even a small reduction in the incidence 
of esophageal cancer could result in 
a substantial reduction in esophageal 
cancer deaths worldwide.
A Primer on the Genetics of 
Alcohol Metabolism
Ethanol is first metabolized primarily 
by alcohol dehydrogenase (ADH) into 
acetaldehyde (Figure 2), a mutagen 
and animal carcinogen that causes 
DNA damage and has other cancer-
promoting effects [5–7]. Acetaldehyde 
is subsequently metabolized to acetate, 
mainly by the enzyme ALDH2 [8]. In 
East Asian populations there are two 
main variants of ALDH2, resulting 
from the replacement of glutamate 
(Glu) at position 487 with lysine (Lys) 
[9]. The Glu allele (also designated 
ALDH2*1) encodes a protein with 
normal catalytic activity, whereas 
the Lys allele (ALDH2*2) encodes 
an inactive protein. As a result, Lys/
Lys homozygotes have no detectable 
Funding: The authors received no specific funding 
for this article. 
Competing Interests: The authors have declared 
that no competing interests exist.
Citation: BrooksPJ, Enoch M-A, Goldman D, Li T-K, 
Yokoyama A (2009) The alcohol flushing response: 
An unrecognized risk factor for esophageal cancer 
from alcohol consumption. PLoS Med 6(3): e1000050. 
doi:10.1371/journal.pmed.1000050
This is an open-access article distributed under the 
terms of the Creative Commons Public Domain 
declaration, which stipulates that, once placed in the 
public domain, this work may be freely reproduced, 
distributed, transmitted, modified, built upon, or 
otherwise used by anyone for any lawful purpose. 
Abbreviations: ADH, alcohol dehydrogenase; 
ALDH2, aldehyde dehydrogenase 2; Glu, glutamate; 
Lys, lysine; OR, odds ratio; UADT, upper aerodigestive 
tract
Philip J. Brooks, Mary-Anne Enoch, and David 
Goldman are in the Laboratory of Neurogenetics, 
National Institute on Alcohol Abuse and Alcoholism, 
National Institutes of Health, Rockville, Maryland, 
United States of America. Ting-Kai Li is the former 
Director of the National Institute on Alcohol Abuse 
and Alcoholism, National Institutes of Health. He is 
now a Professor at the Duke–National University of 
Singapore Graduate Medical School, Durham, North 
Carolina, United States of America. Akira Yokoyama 
is Director of Clinical Research Unit, National Hospital 
Organization Kurihama Alcoholism Center, Nobi, 
Yokosuka, Kanagawa, Japan. Philip J. Brooks and 
Akira Yokoyama were participants in the 2007 
International Agency for Research on Cancer Working 
Group on alcoholic beverage consumption.
* To whom correspondence should be addressed. 
E-mail: pjbrooks@mail.nih.gov; a_yokoyama@
kurihama1.hosp.go.jp
Provenance: Not commissioned; externally peer 
reviewed
Summary Points
sÈ !,$(ÈDEFICIENCYÈRESULTINGÈFROMÈTHEÈ
ALDH2 Lys487 allele contributes to 
both the alcohol flushing response 
and an elevated risk of squamous 
cell esophageal cancer from alcohol 
consumption.
sÈ +NOWLEDGEÈOFÈTHEÈFLUSHINGÈRESPONSEÈISÈ
useful clinically, as it allows doctors to 
identify their ALDH2-deficient patients 
in a simple, cost-effective, and non-
invasive manner. 
sÈ $OCTORSÈSHOULDÈCOUNSELÈTHEIRÈ!,$(

deficient patients to limit alcohol 
consumption and thereby reduce the 
risk of developing esophageal cancer. 
sÈ )NÈVIEWÈOFÈTHEÈAPPROXIMATELYÈÈ
million ALDH2-deficient individuals in 
the world, many of whom now live in 
Western societies, even a small percent 
reduction in esophageal cancers due 
to a reduction in alcohol drinking 
would translate into a substantial 
number of lives saved. 
Research in Translation discusses health interventions 
in the context of translation from basic to clinical 
research, or from clinical evidence to practice.PLoS Medicine  |  www.plosmedicine.org 0259 March 2009  |  Volume 6  |  Issue 3  |  e1000050
ALDH2 activity. Because the Lys allele 
acts in a semi-dominant manner, 
ALDH2 Lys/Glu heterozygotes have 
far less than half of the ALDH2 activity 
of Glu/Glu homozygotes; in fact, 
the reduction in ALDH2 activity in 
heterozygotes is more than 100-fold [8].
Alcohol consumed by ALDH2-
deficient individuals is metabolized to 
acetaldehyde, which accumulates in 
the body due to absent ALDH2 activity 
and results in facial flushing (Figure 
1), nausea, and tachycardia [2]. These 
unpleasant effects are the result of 
diverse actions of acetaldehyde in the 
body, including histamine release 
[10]. Because of the intensity of this 
unpleasant response, ALDH2 Lys/Lys 
homozygotes are unable to consume 
significant amounts of alcohol. As a 
result, they are protected against the 
increased risk of esophageal cancer 
from alcohol consumption [11]. This 
observation also provided evidence for a 
causative role for ethanol in esophageal 
cancer, and a key role for acetaldehyde 
in mediating this effect [11].
ALDH2 Lys/Glu heterozygotes 
experience a less severe manifestation 
of the flushing response due to residual 
but low ALDH2 enzyme activity in 
their cells. As a result, some are able 
to develop tolerance to acetaldehyde 
and the flushing response and become 
habitual heavy drinkers, due in part to 
the influence of societal and cultural 
factors (see below). Therefore, 
paradoxically, it is the more common 
low-activity ALDH2 heterozygous 
genotype that is associated with 
greatest risk of esophageal cancer from 
drinking alcohol. 
Evidence That ALDH2 Deficiency 
Increases the Risk of Alcohol-
Related Squamous Cell Esophageal 
Cancer
Following the first study [12], which 
was conducted in the Japanese 
population, case control studies in 
Japan and Taiwan have consistently 
demonstrated a strong link between 
the risk of esophageal squamous cell 
carcinoma (Figure 3) and alcohol 
consumption in low-activity ALDH2 
heterozygotes, with odds ratios 
(ORs) ranging from 3.7 to 18.1 after 
adjustment for alcohol consumption. 
Moreover, most studies show ORs 
of over 10 for increased risk in 
heterozygotes who are heavy drinkers 
[13,14]. An independent meta-analysis 
has also confirmed an increased 
risk, even among moderate drinking 
heterozygotes [11]. In the Japanese 
and Taiwanese studies, a strikingly 
high proportion (58%–69%) of the 
excessive risk for esophageal cancer is 
attributable to drinking by low-activity 
ALDH2 heterozygous individuals 
[13,14].
Consistent with the results of case 
control studies, prospective studies 
in cancer-free alcoholics have also 
shown that the relative hazard for 
future upper aerodigestive tract 
(UADT) cancers in low-activity ALDH2 
heterozygotes is approximately 12 times 
higher than in individuals with active 
ALDH2 [15]. (The UADT includes 
the oral cavity, pharynx, larynx, and 
esophagus.) In addition, alcohol 
consumption in low-activity ALDH2 
heterozygotes has been associated 
with other cancer-related outcomes, 
including the presence of multiple 
areas of esophageal dysplasia (i.e., 
premalignant lesions) and multiple 
independent UADT cancers [13]. 
It is important to note that ALDH2 
deficiency does not influence 
esophageal cancer risk in non-drinkers 
[11]. Furthermore, the magnitude 
of the ALDH2-associated esophageal 
cancer risk depends on the relative 
importance of alcohol versus other risk 
factors in a given population. In rural 
areas of China, where there is a high 
rate of esophageal cancer but alcohol 
drinking plays a less important role 
than in Japan and Taiwan, there is a 
more modest positive association (ORs, 
1.7 to 3.1) between low-activity ALDH2 
heterozygotes and esophageal cancer 
risk (e.g., [16]).
Acetaldehyde Is Responsible for 
Facial Flushing and Esophageal 
Cancer Risk in ALDH2-Deficient 
Individuals
Acetaldehyde is responsible for the 
facial flushing and other unpleasant 
effects that ALDH2-deficient 
doi:10.1371/journal.pmed.1000050.g001
Figure 1. The Alcohol Flushing Response
Facial flushing in a 22-year-old ALDH2 heterozygote before (left) and after (right) drinking alcohol. 
The individual pictured in this figure has given written consent for publication of his picture using 
the PLoS consent form.
doi:10.1371/journal.pmed.1000050.g002
Figure 2. The Ethanol Metabolic Pathway and the Role of the ALDH2 Variants in 
Acetaldehyde Accumulation
It should be noted that ADH is also polymorphic, and genetic variants in ADH1B interact with the 
ALDH2 variant to modify risk [13].PLoS Medicine  |  www.plosmedicine.org 0260 March 2009  |  Volume 6  |  Issue 3  |  e1000050
individuals experience when they 
drink alcohol [10]. Importantly, there 
is now direct evidence that ALDH2-
deficient individuals experience 
higher levels of acetaldehyde-related 
DNA and chromosomal damage than 
individuals with fully active ALDH2 
when they consume equivalent 
amounts of alcohol, providing a likely 
mechanism for the increased cancer 
risk. A study in Japanese alcoholics [17] 
showed that the amount of mutagenic 
acetaldehyde-derived DNA adducts 
(Figure 4) in white blood cells was 
significantly higher in ALDH2-deficient 
heterozygotes than in individuals with 
active ALDH2 (Table 1). In this study, 
while the two groups were matched 
for alcohol consumption, the ALDH2-
deficient group consumed slightly less 
alcohol on average than the controls. 
Also, ALDH2 heterozygotes who drank 
alcohol had higher levels of white 
blood cells with chromosomal damage 
than drinkers with active ALDH2 [18]. 
Because of these as well as other data, 
the 2007 International Agency for 
Research on Cancer Working Group 
on alcohol and cancer specifically 
noted the substantial mechanistic 
evidence supporting a causal role 
for acetaldehyde in alcohol-related 
esophageal cancer [19]. 
While the UADT is exposed to 
acetaldehyde from alcoholic beverages 
[20] and tobacco smoke, increasing 
evidence points to the metabolism 
of ethanol by microorganisms in 
the oral cavity as an important 
source of acetaldehyde in saliva 
and, by extension, in the esophagus. 
Acetaldehyde levels in saliva are 10–20 
times higher than in blood, due to the 
local formation of acetaldehyde by oral 
microorganisms [21]. Importantly, 
ALDH2 heterozygotes had two to three 
times the acetaldehyde levels in their 
saliva compared to fully active ALDH2 
individuals after a moderate dose of 
oral ethanol [22].
Social and Cultural Factors 
Modulate Alcohol Drinking by 
ALDH2 Heterozygotes 
Alcohol consumption is a social 
activity, and as such can be strongly 
influenced by cultural and social forces. 
In Japan, where the risk of alcohol-
related esophageal cancer in ALDH2 
heterozygotes has been most well 
documented, going out drinking after 
work with colleagues is an essential 
element of Japanese business society, 
and the idea of group harmony is 
particularly powerful. The percentage 
of heavy drinking men who are low-
activity ALDH2 heterozygotes has risen 
substantially in the last few decades, 
in parallel with the proliferation of 
business society in Japan and increases 
in per capita alcohol consumption. 
Harada et al. [23] first reported that 
the frequency of inactive ALDH2 
was very low (only 2%) in Japanese 
alcoholics in 1982. In a later study 
using archival DNA samples, Higuchi 
doi:10.1371/journal.pmed.1000050.g003
Figure 3. A Late-Stage Squamous Cell 
Carcinoma of the Esophagus in a 51-Year-
Old Male with a Known History of Flushing 
and Alcohol Drinking
doi:10.1371/journal.pmed.1000050.g004
Figure 4. Chemical Structures of Deoxyguanosine, the DNA Base That Is the Target for 
Acetaldehyde, As Well As the Acetaldehyde-Derived DNA Lesions Referred To in Table 1 
The atoms in red represent the acetaldehyde-derived chemical modifications.
Five Key Papers in the Field
Harada et al., 1981 [2] The first 
documentation of the relationship 
between ALDH deficiency and the 
flushing reaction.
Yoshida et al., 1984 [9] Identification of 
the amino acid variant responsible for 
ALDH deficiency.
Yokoyama et al., 1996 [12] The first 
evidence demonstrating that ALDH2-
deficient individuals have a dramatically 
elevated risk of esophageal cancer when 
they drink alcohol.
Yokoyama et al., 2003 [25]
Demonstrates that an updated flushing 
questionnaire containing two simple 
questions is approximately 90% sensitive 
and specific for identifying ALDH2-
deficient individuals. 
Baan et al., 2007 [19] Summary of the 
conclusions from the 2007 International 
Agency for Research on Cancer Working 
Group on the Consumption of Alcoholic 
Beverages. This is the first report to 
conclude that ethanol in alcoholic 
beverages is carcinogenic to humans.
The report also adds the female breast 
and colorectum to the list of sites for 
alcohol-related carcinogenesis and notes 
substantial mechanistic evidence linking 
acetaldehyde to esophageal cancer risk 
based on studies from ALDH2-deficient 
individuals.PLoS Medicine  |  www.plosmedicine.org 0261 March 2009  |  Volume 6  |  Issue 3  |  e1000050
et al. [24] determined that in 1979, 3% 
of Japanese alcoholics were ALDH2 
heterozygotes, compared with 8% 
in 1986 and 13% in 1992. In a more 
recent study, approximately 26% of 
heavy drinking (consuming more 
than about 400 g of ethanol per week) 
men in Tokyo were ALDH2 Lys487 
heterozygotes [35]. In other East Asian 
countries, estimates of the percentage 
of alcoholics who are low-activity 
ALDH2 heterozygotes range from 17% 
in Taiwan in 1999 [26] to 4% in Korea 
in 2007 [27]. Taken together, these 
observations indicate that the inhibitory 
effect of heterozygous ALDH2-
deficiency on alcohol consumption can 
be strongly influenced by local social 
and cultural factors which may change 
over time. 
There are many East Asians now 
living in Western societies, particularly 
at universities and in metropolitan 
areas. A sub-population of special 
concern is ALDH2-deficient university 
students who may face peer pressure 
for heavy drinking and binge drinking. 
Furthermore, anecdotal evidence 
indicates that some young people 
view the facial flushing response 
as a cosmetic problem and use 
antihistamines in an effort to blunt 
the flushing while continuing to drink 
alcohol [28]. This practice is expected 
to increase the likelihood of developing 
esophageal cancer. 
Education and Early Detection Can 
Reduce the Global Health Burden 
of Esophageal Cancer 
Clinicians who treat patients of East 
Asian descent need to be aware of the 
risk of esophageal cancer from alcohol 
consumption in their ALDH2-deficient 
patients. Importantly, clinicians can 
determine whether an individual of 
East Asian descent is ALDH2 deficient 
simply by asking whether they have 
experienced the alcohol flushing 
response. In the Japanese population, 
ALDH2 deficiency can be identified 
accurately based on the answers to 
a flushing questionnaire consisting 
of two questions (see Box 1) about 
previous episodes of facial flushing 
after drinking alcohol [25]. The two 
questions can be easily included as part 
of a standard clinical interview. In a 
Japanese male population, the flushing 
questionnaire had a 90% sensitivity 
and 88% specificity [25] and a positive 
predictive value of 87% (based on the 
tabulated data in [25]). The flushing 
questionnaire gave a similarly high 
sensitivity (88%) and specificity (92%) 
when administered to Japanese women 
[29].
Once ALDH2-deficient patients 
have been identified, they should be 
informed about their elevated risk of 
developing esophageal cancer risk 
from drinking alcohol. As can be seen 
from Figure 5, ALDH2 deficiency 
increases esophageal cancer risk 
at all three drinking levels, but the 
slope of the line relating alcohol 
consumption to esophageal cancer 
risk is steeper in ALDH2-deficient 
individuals. Clinicians might therefore 
use this graph to explain the increased 
risk when counseling their ALDH2-
deficient patients to reduce alcohol 
consumption.
The ORs in Figure 5 are adjusted 
for smoking. However, patients should 
also be informed that smoking further 
increases the esophageal cancer risk in 
a synergistic manner with alcohol [30]. 
As noted above, cigarette smoking 
dramatically increases acetaldehyde 
levels in saliva, and ALDH2-deficient 
individuals have a reduced capacity to 
clear salivary acetaldehyde.
For patients at high risk of 
esophageal cancer, doctors should also 
consider endoscopy for early cancer 
Table 1. Acetaldehyde-Derived DNA Damage in ALDH2-Deficient Alcoholics
Acetaldehyde-Derived DNA Adduct ALDH2 Genotype
ALDH2487 Glu/Glu
(*1/*1) [n = 19]
ALDH2487 Glu/Lys
(*1/*2) [n = 25]
p-Value
N2-Et-dG 17.8 ± 15.9 130 ± 52 0.03
α-S-Me-γ-OH-PdG 42.9 ± 6.0 92.4 ± 12.9 0.01
α-R-Me-γ-OH-PdG 61.3 ± 6.4 114 ± 15 0.02
Values are means ± standard error of the mean (fmol/µM dG); p-values were calculated by the Wilcoxon-Mann-Whitney 
test (N2-Et-dG) and t-test (α-Me-γ-OH-PdGs).
For illustrations of these adducts, see Figure 4. These data are from [17].
α-R-Me-γ-OH-PdG, α-R-methyl-γ-hydroxy-1, N2-propanodeoxyguanosine; α-S-Me-γ-OH-PdG, α-S-methyl-γ-hydroxy-1, 
N2-propanodeoxyguanosine; N2-Et-dG, N2-ethyl-deoxyguanosine.
doi:10.1371/journal.pmed.1000050.t001
doi:10.1371/journal.pmed.1000050.g005
Figure 5. Odds Ratios for Esophageal Cancer at Different Amounts of Alcohol Consumption 
In Relation To the Flushing Response
Alcohol consumption amounts: low, 1–8.9 units/week; moderate, 9–17.9 units/week; high, ≥18 
units/week; where 1 unit = 22 g of ethanol. The referent (OR = 1) is never/rare drinkers (<1 unit/
week) of either genotype. Odds ratios were adjusted for age, frequency of drinking strong alcohol 
beverages, pack-years of smoking, and intake of fruit and green-yellow vegetables, based on a 
multiple logistic regression model. Error bars are 95% confidence intervals. The graph is based on 
the data in [25]. PLoS Medicine  |  www.plosmedicine.org 0262 March 2009  |  Volume 6  |  Issue 3  |  e1000050
detection. A health risk assessment tool 
to select candidates for endoscopic 
cancer screening, including data on 
alcohol flushing as well as alcohol 
consumption, smoking, and dietary 
habits, is currently being developed 
and validated [31]. Using a version of 
the health risk assessment that includes 
the flushing questionnaire as a major 
component, it has been estimated 
that approximately 58% of esophageal 
cancers in the Japanese population 
could be detected by screening only the 
individuals with the top 10% risk scores 
[31].
When detected early, esophageal 
cancer can be treated by endoscopic 
mucosectomy, a standard and relatively 
non-invasive procedure. However, once 
the cancer has grown large enough to 
penetrate the submucosal layer, the 
likelihood of lymph node metastasis 
increases significantly [32]. Only about 
20% of esophageal cancer patients 
survive three years after diagnosis [3], 
emphasizing the importance of disease 
prevention.
ALDH2-deficient university students 
may have their first experiences with 
heavy drinking while at university. 
Therefore, it is particularly important 
for university health professionals to 
be aware of the relationship between 
ALDH2 deficiency, facial flushing, 
and alcohol-related cancer risk. 
Informing ALDH2-deficient young 
people of their risk of esophageal 
cancer from alcohol drinking 
represents a valuable opportunity for 
cancer prevention. However, most 
of the data on the accuracy of the 
flushing questionnaire have come 
from individuals over 40 years old. 
To assess ALDH2 deficiency in young 
people with little experience of alcohol 
consumption, an ethanol patch test 
(see Box 1) can be used [13]. In 
the patch test, ethanol is applied to 
the skin, where it is metabolized to 
acetaldehyde. (Both ADH and ALDH 
can be detected in skin fibroblasts 
[33].) If the acetaldehyde is not 
further metabolized to acetate, it 
causes vasodilation, which is detected 
visually as localized erythema. Like the 
flushing questionnaire, the ethanol 
patch test is simple and inexpensive to 
perform, and the sensitivity, specificity, 
and positive predictive value for 
inactive ALDH2 have been shown to 
be more than 90% in Japanese youth 
[34].
How Many Cancers Could Be 
Prevented by Reducing Alcohol 
Consumption in ALDH2-Deficient 
Individuals?
Finally, it is important to consider 
how many esophageal cancer cases 
might be prevented if ALDH2-
deficient individuals reduced alcohol 
consumption. To address this question, 
the tabulated data of [35] were used to 
recalculate the population-attributable 
risk by Bruzzi’s method [36]. The 
results of this calculation indicate that 
if moderate or heavy drinking ALDH2 
heterozygotes were instead only light 
drinkers, 53% of esophageal squamous 
cell carcinomas might be prevented in 
the Japanese male population.  
Supporting Information
Alternative Language Summary S1.
Translation of the article summary into 
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